Word

Status

Pending

Status Code

688

Status Date

Tuesday, January 9, 2024

Serial Number

97672474

Mark Type

2000

Filing Date

Thursday, November 10, 2022

Published for Opposition

Tuesday, November 14, 2023

Trademark Owner History

Eli Lilly and Company - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

The mark consists of two color lines in aqua and gold folding and extending in opposite directions creating a contour in the color of slate to form a diamond shape in the center. The color white represents background and/or transparent areas and is not claimed as a feature of the mark.
The color(s) slate, aqua and gold is/are claimed as a feature of the mark.

Trademark Events

Jan 9, 2024

Noa E-Mailed - Sou Required From Applicant

Nov 14, 2023

Official Gazette Publication Confirmation E-Mailed

Nov 14, 2023

Published For Opposition

Oct 25, 2023

Notification Of Notice Of Publication E-Mailed

Oct 12, 2023

Approved For Pub - Principal Register

Oct 11, 2023

Teas/Email Correspondence Entered

Oct 11, 2023

Correspondence Received In Law Office

Oct 11, 2023

Teas Response To Office Action Received

Aug 24, 2023

Notification Of Non-Final Action E-Mailed

Aug 24, 2023

Non-Final Action E-Mailed

Aug 24, 2023

Non-Final Action Written

Aug 14, 2023

Assigned To Examiner

Dec 2, 2022

Notice Of Design Search Code E-Mailed

Dec 1, 2022

New Application Office Supplied Data Entered

Nov 14, 2022

New Application Entered